Jim Simons Kal Vista Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$11.07 - $16.04 $2.23 Million - $3.23 Million	201,184 Added 475.61%	243,484 $2.89 Million
Q4 2023 Feb 13, 2024	SELL	$7.58 - $12.25 $203,144 - $328,300	-26,800 Reduced 38.78%	42,300 $518,000
Q3 2023 Nov 14, 2023	SELL	$8.95 - $11.35 $660,760 - $837,947	-73,828 Reduced 51.65%	69,100 $665,000
Q2 2023 Aug 11, 2023	BUY	$7.73 - $10.57 $481,795 - $658,806	62,328 Added 77.33%	142,928 $1.29 Million
Q1 2023 May 12, 2023	SELL	$6.3 - $8.39 $86,310 - $114,943	-13,700 Reduced 14.53%	80,600 $634,000
Q4 2022 Feb 13, 2023	SELL	$4.2 - $14.24 $125,160 - $424,352	-29,800 Reduced 24.01%	94,300 $637,000
Q3 2022 Nov 14, 2022	SELL	$9.85 - $16.83 $1.04 Million - $1.77 Million	-105,270 Reduced 45.9%	124,100 $1.8 Million
Q2 2022 Aug 12, 2022	BUY	$8.16 - $15.1 $1.73 Million - $3.21 Million	212,570 Added 1265.3%	229,370 $2.26 Million
Q1 2022 May 13, 2022	SELL	$11.2 - $16.97 $63,022 - $95,490	-5,627 Reduced 25.09%	16,800 $248,000
Q4 2021 Feb 11, 2022	SELL	$12.36 - $18.28 $13,608 - $20,126	-1,101 Reduced 4.68%	22,427 $297,000
Q3 2021 Nov 12, 2021	BUY	$17.11 - $24.49 $402,564 - $576,200	23,528 New	23,528 $411,000
Q2 2021 Aug 13, 2021	SELL	$23.12 - $29.91 $3.55 Million - $4.59 Million	-153,428 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$14.69 - $42.57 $1.53 Million - $4.43 Million	104,000 Added 210.41%	153,428 $3.94 Million
Q4 2020 Feb 10, 2021	BUY	$12.88 - $19.47 $636,632 - $962,363	49,428 New	49,428 $939,000
Q3 2020 Nov 13, 2020	SELL	$9.83 - $13.99 $406,431 - $578,430	-41,346 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$6.75 - $12.89 $41,728 - $79,685	-6,182 Reduced 13.01%	41,346 $500,000
Q1 2020 May 14, 2020	BUY	$5.8 - $18.56 $275,662 - $882,119	47,528 New	47,528 $364,000
Q4 2019 Feb 13, 2020	SELL	$10.31 - $17.81 $196,178 - $338,888	-19,028 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$11.6 - $21.67 $220,724 - $412,336	19,028 New	19,028 $221,000
Q2 2019 Aug 12, 2019	SELL	$18.44 - $30.89 $2.95 Million - $4.94 Million	-159,929 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$16.51 - $31.1 $318,643 - $600,230	-19,300 Reduced 10.77%	159,929 $4.58 Million
Q4 2018 Feb 13, 2019	BUY	$16.21 - $24.06 $2.91 Million - $4.31 Million	179,229 New	179,229 $3.54 Million

Others Institutions Holding KALV

# of Institutions

125

Shares Held

47.8M

Call Options Held

551K

Put Options Held

110K

Vr Adviser, LLC New York, NY

6.25M
Shares

$56 Million
7.5% of portfolio
Tang Capital Management LLC San Diego, CA

4.32M
Shares

$38.7 Million
4.26% of portfolio
Suvretta Capital Management, LLC New York, NY

4.21M
Shares

$37.7 Million
1.92% of portfolio
Vestal Point Capital, LP New York, NY

4M
Shares

$35.8 Million
3.51% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.69M
Shares

$33 Million
2.3% of portfolio

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $220M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account